A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis
Clinical trial NCT04963270 · TERMINATED
Trial details
- NCT number
- NCT04963270
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2024-01-29
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.